William R. Gwin

An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models

Wenle Xia, Emanual Petricoin, Sumin Zhao et al. · Breast Cancer Research · 2013 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study

Ni Jiang, Guoliang Qiao, Xiaoli Wang et al. · Clinical Cancer Research · 2017 · 82 citations

Medicine, Immunology, Oncology +16

Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study

Erika J. Crosby, William R. Gwin, Kimberly Blackwell et al. · Clinical Cancer Research · 2019 · 80 citations · Full text

Medicine, Immunology, Oncology +17

Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial

Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso et al. · Journal of Clinical Oncology · 2022 · 80 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype

Qing Cheng, Jeffrey T. Chang, William R. Gwin et al. · Breast Cancer Research · 2014 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +15